Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-30

Clinical Trial Update: Heart Failure With Reduced Ejection Fraction: Adjuvant Therapy With Neurostimulation and Chlorella Pyrenoidosa (HD-tDCS) [NA]

View source ↗

Summary

A clinical trial from Federal University of Paraíba is evaluating adjuvant neurostimulation with HD-tDCS and chlorella pyrenoidosa for heart failure with reduce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorella pyrenoidosa (Chlorella pyrenoidosa)
  • HD-tDCS (High-definition transcranial direct current stimulation)

Snippet

Sponsor: Federal University of Paraíba | Conditions: Heart Failure, Reduced Ejection Fraction, Vitamin B12 Deficiency | NA | Status: ACTIVE_NOT_RECRUITING